Office of the Secretary; Notice of Meeting, 46893-46894 [2024-11848]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 105 / Thursday, May 30, 2024 / Notices
Place: National Center for Complementary
and Integrative, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Mei Qin, MD, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, Division of Extramural Activities,
NCCIH/NIH, 6707 Democracy Blvd., Suite
401, Bethesda, MD 20892, mei.qin@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: May 23, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Development of Medical
Countermeasures for Biodefense and
Emerging Infectious Diseases, Research Area
003—In Vitro Diagnostics (N01).
Date: June 25–July 2, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F52A,
Rockville, MD 20852 (Video Assisted
Meeting).
Contact Person: Shilpakala Ketha, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3F52A, Rockville, MD
20852, (301) 761–6821, shilpa.ketha@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
Jkt 262001
[FR Doc. 2024–11858 Filed 5–29–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary; Notice of
Meeting
BILLING CODE 4140–01–P
20:45 May 29, 2024
Dated: May 24, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2024–11854 Filed 5–29–24; 8:45 am]
VerDate Sep<11>2014
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
Interagency Autism Coordinating
Committee.
This will be a hybrid meeting held inperson and virtually and will be open to
the public as indicated below.
Individuals who plan to attend inperson or view the virtual meeting and
need special assistance or other
accommodations should notify the
Contact Person listed below at least
seven (7) business days prior to the
meeting. The meeting can be accessed
from the NIH Videocast website (https://
videocast.nih.gov/).
Name of Committee: Interagency Autism
Coordinating Committee.
Date: July 10, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To discuss committee business,
updates, and issues related to autism
research and services activities.
Place: National Institute of Mental Health
(NIMH), Neuroscience Center (NSC), 6001
Executive Boulevard, First Floor Conference
Room, Rockville, MD 20852 (In Person and
Virtual).
Cost: The meeting is free and open to the
public.
Registration: A registration web link will
be posted on the IACC website
(www.iacc.hhs.gov) prior to the meeting. Preregistration is recommended.
Deadlines: Public Comment Due Date:
Monday, June 24, by 5:00 p.m. ET, Public
Comment Guidelines, For public comment
instructions, see below.
Contact Person: Ms. Rebecca Martin, Office
of National Autism Coordination, National
Institute of Mental Health, NIH, Phone: 301–
435–0886, Email: IACCPublicInquiries@
mail.nih.gov.
Public Comments: The IACC
welcomes written and oral/virtual
public comments from members of the
autism community and asks the
community to review and adhere to its
Public Comment Guidelines. In the
2021–2023 IACC Strategic Plan, the
IACC lists the ‘‘Spirit of Collaboration’’
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
46893
as one of its core values, stating that,
‘‘We will treat others with respect, listen
with open minds to the diverse lived
experiences of people on the autism
spectrum and their families, consider
multiple solutions, and foster
discussions where participants can
comfortably share different opinions.’’
In keeping with this core value, the
IACC and the NIMH Office of National
Autism Coordination (ONAC) ask that
members of the public who provide
public comments or participate in
meetings of the IACC also adhere to this
core value.
A limited number of slots are
available for individuals to provide a
∼3-minute summary or excerpt of their
written comment to the Committee
during the meeting either in person or
via videoconference. For those
interested in that opportunity, please
indicate ‘‘Interested in providing oral/
virtual comment’’ in your written
submission, along with your name,
address, email, phone number, and
professional/organizational affiliation so
that ONAC staff can contact you if a slot
is available.
For any given meeting, priority for
comment slots will be given to
individuals and organizations that have
not previously provided comments in
the current calendar year. This will help
ensure that as many individuals and
organizations as possible have an
opportunity to share comments.
Commenters going over their allotted 3minute slot may be asked to conclude
immediately in order to allow other
comments and the rest of the meeting to
proceed on schedule.
Public comment submissions received
by 5:00 p.m. ET on Monday, June 24,
2024, will be provided to the Committee
prior to the meeting for their
consideration. Any written comments
received after 5:00 p.m. ET, Monday,
June 24, 2024, may be provided to the
Committee either before or after the
meeting, depending on the volume of
comments received and the time
required to process them in accordance
with privacy regulations and other
applicable Federal policies. The
Committee is not able to respond
individually to comments. All public
comments become part of the public
record. Attachments of copyrighted
publications are not permitted, but web
links or citations for any copyrighted
works cited may be provided. For public
comment guidelines, see: https://
iacc.hhs.gov/meetings/publiccomments/guidelines/.
Technical issues: If you experience
any technical problems with the
webcast, please email
IACCPublicInquiries@mail.nih.gov.
E:\FR\FM\30MYN1.SGM
30MYN1
46894
Federal Register / Vol. 89, No. 105 / Thursday, May 30, 2024 / Notices
Disability Accommodations: All IACC
Full Committee Meetings provide
Closed Captioning through the NIH
videocast website. Individuals whose
full participation in the meeting will
require special accommodations (e.g.,
sign language or interpreting services,
etc.) must submit a request to the
Contact Person listed on the notice at
least seven (7) business days prior to the
meeting. Such requests should include
a detailed description of the
accommodation needed and a way for
the IACC to contact the requester if
more information is needed to fill the
request. Special requests should be
made at least seven (7) business days
prior to the meeting; last-minute
requests may be made but may not be
possible to accommodate.
Security: During the check-in process,
attendees will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit. Pre-registration is
recommended. Seats will be on a first
come, first served basis, with expedited
check-in for those who are preregistered. Meeting schedule subject to
change.
More Information: Information about
the IACC is available on the website:
https://www.iacc.hhs.gov.
Dated: May 23, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–11848 Filed 5–29–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ddrumheller on DSK120RN23PROD with NOTICES1
National Heart, Lung, and Blood
Institute; Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Sickle Cell Disease
Advisory Committee.
The meeting will be held as a virtual
meeting and will be open to the public
as indicated below. Individuals who
plan to view the virtual meeting and
need special assistance or other
reasonable accommodations to view the
meeting, should notify the Contact
Person listed below in advance of the
meeting.
Name of Committee: Sickle Cell Disease
Advisory Committee.
Date: July 23, 2024.
Time: 3:00 p.m. to 5:00 p.m.
VerDate Sep<11>2014
20:03 May 29, 2024
Jkt 262001
Agenda: NHLBI Sickle Cell Disease
Program Updates.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
The event is free and open to the public,
however, registration is required. Please use
this link to register: https://
nih.zoomgov.com/webinar/register/WN_
RZK8GeENQWO9DmGH3bBFnQ.
Contact Person: Julie A. Panepinto, MD,
MSPH, DFO/Executive Secretary SCDAC,
Director, Division of Blood Diseases and
Resources, 6701 Rockledge Drive, Suite 9166,
Bethesda, MD 20892, (301) 435–0080,
NHLBIDBDRGrantResource@nhlbi.nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nhlbi.nih.gov/advisory-and-peerreview-committees/nhlbi-sickle-cell-diseaseadvisory-committee, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: May 23, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–11856 Filed 5–29–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Stakeholder Measures and
Advocate Forms at the National Cancer
Institute (NCI)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
PO 00000
Notice.
Frm 00042
Fmt 4703
Sfmt 4703
In compliance with the
requirement of the Paperwork
Reduction Act of 1995 to provide
opportunity for public comment on
proposed data collection projects, the
National Institutes of Health, National
Cancer Institute (NCI) will publish
periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Amy Williams, Director of the
Office of Advocacy Relations (OAR),
NCI, NIH, 31 Center Drive, Bldg. 31,
Room 10A28, MSC 2580, Bethesda, MD
20892, call non-toll-free number 240–
781–3406, or email your request,
including your address, to
amy.williams@nih.gov. Formal requests
for additional plans and instruments
must be requested in writing.
SUPPLEMENTARY INFORMATION: Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimizes
the burden of the collection of
information on those who are to
respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Proposed Collection Title:
Stakeholder Measures and Advocate
Forms at the National Cancer Institute
(NCI), 0925–0774, Expiration Date10/
31/2024, REVISION, National Cancer
Institute (NCI), National Institutes of
Health (NIH).
Need and Use of Information
Collection: This is a request for OMB to
approve the revision of the collection
titled, ‘‘Stakeholder Measures and
SUMMARY:
E:\FR\FM\30MYN1.SGM
30MYN1
]]>Agencies
[Federal Register Volume 89, Number 105 (Thursday, May 30, 2024)]
[Notices]
[Pages 46893-46894]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-11848]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the Interagency Autism Coordinating
Committee.
This will be a hybrid meeting held in-person and virtually and will
be open to the public as indicated below. Individuals who plan to
attend in-person or view the virtual meeting and need special
assistance or other accommodations should notify the Contact Person
listed below at least seven (7) business days prior to the meeting. The
meeting can be accessed from the NIH Videocast website (https://videocast.nih.gov/).
Name of Committee: Interagency Autism Coordinating Committee.
Date: July 10, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To discuss committee business, updates, and issues
related to autism research and services activities.
Place: National Institute of Mental Health (NIMH), Neuroscience
Center (NSC), 6001 Executive Boulevard, First Floor Conference Room,
Rockville, MD 20852 (In Person and Virtual).
Cost: The meeting is free and open to the public.
Registration: A registration web link will be posted on the IACC
website (www.iacc.hhs.gov) prior to the meeting. Pre-registration is
recommended.
Deadlines: Public Comment Due Date: Monday, June 24, by 5:00
p.m. ET, Public Comment Guidelines, For public comment instructions,
see below.
Contact Person: Ms. Rebecca Martin, Office of National Autism
Coordination, National Institute of Mental Health, NIH, Phone: 301-
435-0886, Email: [email protected].
Public Comments: The IACC welcomes written and oral/virtual public
comments from members of the autism community and asks the community to
review and adhere to its Public Comment Guidelines. In the 2021-2023
IACC Strategic Plan, the IACC lists the ``Spirit of Collaboration'' as
one of its core values, stating that, ``We will treat others with
respect, listen with open minds to the diverse lived experiences of
people on the autism spectrum and their families, consider multiple
solutions, and foster discussions where participants can comfortably
share different opinions.'' In keeping with this core value, the IACC
and the NIMH Office of National Autism Coordination (ONAC) ask that
members of the public who provide public comments or participate in
meetings of the IACC also adhere to this core value.
A limited number of slots are available for individuals to provide
a ~3-minute summary or excerpt of their written comment to the
Committee during the meeting either in person or via videoconference.
For those interested in that opportunity, please indicate ``Interested
in providing oral/virtual comment'' in your written submission, along
with your name, address, email, phone number, and professional/
organizational affiliation so that ONAC staff can contact you if a slot
is available.
For any given meeting, priority for comment slots will be given to
individuals and organizations that have not previously provided
comments in the current calendar year. This will help ensure that as
many individuals and organizations as possible have an opportunity to
share comments. Commenters going over their allotted 3-minute slot may
be asked to conclude immediately in order to allow other comments and
the rest of the meeting to proceed on schedule.
Public comment submissions received by 5:00 p.m. ET on Monday, June
24, 2024, will be provided to the Committee prior to the meeting for
their consideration. Any written comments received after 5:00 p.m. ET,
Monday, June 24, 2024, may be provided to the Committee either before
or after the meeting, depending on the volume of comments received and
the time required to process them in accordance with privacy
regulations and other applicable Federal policies. The Committee is not
able to respond individually to comments. All public comments become
part of the public record. Attachments of copyrighted publications are
not permitted, but web links or citations for any copyrighted works
cited may be provided. For public comment guidelines, see: https://iacc.hhs.gov/meetings/public-comments/guidelines/.
Technical issues: If you experience any technical problems with the
webcast, please email [email protected].
[[Page 46894]]
Disability Accommodations: All IACC Full Committee Meetings provide
Closed Captioning through the NIH videocast website. Individuals whose
full participation in the meeting will require special accommodations
(e.g., sign language or interpreting services, etc.) must submit a
request to the Contact Person listed on the notice at least seven (7)
business days prior to the meeting. Such requests should include a
detailed description of the accommodation needed and a way for the IACC
to contact the requester if more information is needed to fill the
request. Special requests should be made at least seven (7) business
days prior to the meeting; last-minute requests may be made but may not
be possible to accommodate.
Security: During the check-in process, attendees will be asked to
show one form of identification (for example, a government-issued photo
ID, driver's license, or passport) and to state the purpose of their
visit. Pre-registration is recommended. Seats will be on a first come,
first served basis, with expedited check-in for those who are pre-
registered. Meeting schedule subject to change.
More Information: Information about the IACC is available on the
website: https://www.iacc.hhs.gov.
Dated: May 23, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-11848 Filed 5-29-24; 8:45 am]
BILLING CODE 4140-01-P
